In vivo and in vitro antiviral activities of calycosin-7-o- β-D-glucopyranoside against coxsackie virus B3

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 1, 2009, Pages 68-73

  Zhu, Haiyan ^a,b   Zhang, Yuanyuan ^c   Ye, Guan ^a   Li, Zhixiong ^a   Zhou, Pei ^b   Huang, Chenggang ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Astragalus membranaceus; Calycosin 7 O D glucopyranoside; Coxsackie virus B3; Viral myocarditis

Indexed keywords

CALYCOSIN 7 O BETA DEXTRO GLUCOPYRANOSIDE; ISOFLAVONOID; RIBAVIRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; ASTRAGALUS MEMBRANACEUS; CHINESE HERB; CHINESE MEDICINE; CONTROLLED STUDY; COXSACKIE VIRUS B3; CYTOPATHOGENIC EFFECT; DRUG CYTOTOXICITY; DRUG INDICATION; DRUG PURITY; DRUG STRUCTURE; HEART INDEX; HEART LEFT VENTRICLE FUNCTION; HISTOPATHOLOGY; IC 50; IN VITRO STUDY; IN VIVO STUDY; M MODE ECHOCARDIOGRAPHY; MALE; MOUSE; NONHUMAN; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT DURATION; VERO CELL; VIRUS INHIBITION; VIRUS MYOCARDITIS; VIRUS TITRATION;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; COXSACKIEVIRUS INFECTIONS; ECHOCARDIOGRAPHY; ENTEROVIRUS B, HUMAN; GLUCOSIDES; ISOFLAVONES; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; MYOCARDIUM; TIME FACTORS; VERO CELLS;

EID: 59949096966     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.68     Document Type: Article

References (21)

1. Luigi B., Evelyn R., Hermes D., Am. J. Health-Syst. Pharm., 65, 132-137 (2008).
2. Yang Y. Z., Jin P. Y., Guo Q., Chin. Med. J., 103, 14-17 (1990).
3. Yang Y. Z., Jin P. Y., Guo Q., Chin. Med. J., 103, 304-307 (1990).
4. Rios J. L., Waterman P. G., Phytother. Res., 11, 411-418 (1997).
5. Kim E. J., Yang K. S., Yakhak Hoechi, 45, 529-535 (2001).
6. Yao M. C., Qi Y., Zhongguo Yesheng Ziyuan, 19, 33-36 (2000).
7. Zhang Y. Y., Zhu H. Y., Huang C. G., J. Cardiovasc. Pharmacol., 47, 190-195 (2006).
8. Kim E. J., Jin O. O., Lee S. K., Yang K. S., Saengyak Hakhoechi, 32, 311-315 (2001).
9. Huang C. G., Zhang Y. Y., Zhu H. Y., Ma C. H., Ye G., Fan M. S., Tang Y. H., Li Z. X., Sun Z. L., Patent No. :CN1813711 (2006).
10. Wu T., Annie B., Gu L. H., Wang Z. T., Liu H. P., Cheng X. M., Branford-White C. J., Hu Z. B., Fitoterapia, 76, 157-165 (2005).
11. Ye G., Ma R. R., Li Z. X., Wang H., Zhu H. Y., Sun Z. L., Huang C. G., Biomed. Chromatogr., 21, 762-767 (2007).
12. Schmidtke M., Schnittler U., Jahn B., Dahse H., Stelzner A., J. Virol. Methods, 95, 133-143 (2001).
13. Malin L., Truls R., German C., Finn W., Elmir O., J. Card. Fail., 14, 161-166 (2008).
14. Feng J., Dong W., Quan X. Z., Di R., Ma C. M., Huang L., Qin C., Zhang L. F., Int. J. Cardiol., 128, 83-90 (2008).
15. Stanic M., Pathol. Microbiol., 26, 298-302 (1963).
16. Kanda T., Tanaka T., Sekiguchi K., Seta Y., Kurimoto M., Wilson McManus J. E., Nagai R., Yang D., McManus B. M., Kobayashi I., J. Mol. Cell. Cardiol., 32, 2163-2171 (2000).
17. Kyung-Soo K., Gunter H. F., Nora M., Chapman., Steven T., Rev. Med. Virol., 11, 355-368 (2000).
18. Hirschman S. Z., Hammer G. S., Am. J. Cardiol., 34, 224-232 (1974).
19. Fujioka S., Kitaura Y., BioDrugs, 5, 791-799 (2001).
20. Kearney M. T., Cotton J. M., Richardson P. J., Postgrad. Med. J., 77, 4-10 (2001).
21. Zhou J. Y., Fan Y., Kong J. L., Wu D. Z., Hu Z. B., Zhongguo Zhong Yao Za Zhi, 25, 300-302 (2000).